Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: CCA, FVT

Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024


EMERYVILLE, Calif., April 24, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the U.S. financial markets close.

Dynavax will host a conference call and live audio webcast on Wednesday, May 8, 2024, at 4:30 p.m. ET/1:30 p.m. PT.

The live audio webcast may be accessed through the "Events & Presentations" page on the "Investors" section of the Company's website at https://investors.dynavax.com/events-presentations. A replay of the webcast will be available for 30 days following the live event.

To dial into the call, participants will need to register for the call using the caller registration link. It is recommended that participants dial into the conference call or log into the webcast approximately 10 minutes prior to the call.

About Dynavax
Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the U.S., the European Union and Great Britain for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older, and CpG 1018® adjuvant, currently used in multiple adjuvanted COVID-19 vaccines. Dynavax is advancing CpG 1018 adjuvant as a premier vaccine adjuvant with adjuvanted vaccine clinical programs for shingles and Tdap, and through global collaborations, currently focused on adjuvanted vaccines for COVID-19, plague, seasonal influenza and universal influenza. For more information about our marketed products and development pipeline, visit www.dynavax.com and follow Dynavax on LinkedIn and Twitter.

For Investors/Media:
Paul Cox
[email protected]
510-665-0499 

Nicole Arndt
[email protected]
510-665-7264

SOURCE Dynavax Technologies


These press releases may also interest you

at 15:00
CSX and STG Logistics Extend Strategic Partnership to Drive Intermodal Solutions, Enhance Drayage Service
STG Logistics, Inc., a leading provider of transportation and logistics solutions, is pleased to announce a strengthened partnership with CSX railroad, including an expanded relationship to facilitate drayage services to support their door-to-door...

at 14:55
AAPKI VENTURES INC. CORPORATE UPDATE
Aapki Ventures Inc. ("AAPKI" or the "Company") (FFT: 64Q), announces that Parmjeet Johal has resigned from the Board of the Company, effective immediately, due to personal reasons. As replacements for Mr. Johal, the Company is pleased to announce...

at 14:47
PrideStaff Named to Forbes' America's Best Professional Recruiting Firms List for Eighth Consecutive Year
During a year marked by intense labor shortages, PrideStaff, a nationally franchised staffing organization, is pleased to announce that it ranked among the top 200 firms on Forbes' 2024 List of America's Best...

at 14:46
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on May 9, 2024
Regen BioPharma, Inc. , a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the Emerging Growth Conference...

at 14:41
BondIt Media Capital and Cineverse form Unique and Innovative Partnership to Finance Film Distribution
BondIt Media Capital has closed a new co-financing partnership with Cineverse , an innovative streaming technology and entertainment company.  Through this deal, BondIt will provide financing to be used for North American production, acquisition,...

at 14:37
OtterBox Statement Series Studio for New Apple iPad Pro and iPad Air Devices
OtterBox is making a statement with an innovative new case design for iPad Pro 13-inch, iPad Pro 11-inch, iPad Air 13-inch and iPad Air 11-inch. Designed with the working professional in mind, Statement Series Studio provides protection and...

More news about Science and technology...


News published on and distributed by: